H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 137 Citations 81,150 1,020 World Ranking 758 National Ranking 21

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Endocrinology
  • Diabetes mellitus

His scientific interests lie mostly in Internal medicine, Endocrinology, Kidney disease, Diabetes mellitus and Renal function. The study incorporates disciplines such as Surgery and Cardiology in addition to Internal medicine. His Surgery study combines topics in areas such as Hazard ratio, Incidence and Risk factor.

His research integrates issues of Gastroenterology, Parathyroid hormone and Urology in his study of Endocrinology. As part of the same scientific family, he usually focuses on Kidney disease, concentrating on Angiotensin II and intersecting with Irbesartan. As part of one scientific family, Eberhard Ritz deals mainly with the area of Type 2 diabetes, narrowing it down to issues related to the Microalbuminuria, and often Olmesartan.

His most cited work include:

  • Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes (4777 citations)
  • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. (2070 citations)
  • Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency (1525 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Endocrinology, Kidney disease, Kidney and Blood pressure. The various areas that Eberhard Ritz examines in his Internal medicine study include Diabetes mellitus and Cardiology. Diabetes mellitus is represented through his Nephropathy, Type 2 diabetes and Microalbuminuria research.

His Endocrinology research is multidisciplinary, relying on both Parathyroid hormone, Calcium and Urology. Eberhard Ritz combines subjects such as Nephrology, Surgery, Intensive care medicine, Disease and Proteinuria with his study of Kidney disease. His Pathology research extends to Kidney, which is thematically connected.

He most often published in these fields:

  • Internal medicine (69.60%)
  • Endocrinology (49.76%)
  • Kidney disease (20.08%)

What were the highlights of his more recent work (between 2007-2019)?

  • Internal medicine (69.60%)
  • Endocrinology (49.76%)
  • Kidney disease (20.08%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Endocrinology, Kidney disease, Renal function and Blood pressure. His study in Internal medicine is interdisciplinary in nature, drawing from both Diabetes mellitus, Type 2 diabetes and Cardiology. His Type 2 diabetes research includes themes of Placebo and Microalbuminuria.

In his study, Surgery and Hemodialysis is strongly linked to Hazard ratio, which falls under the umbrella field of Cardiology. His studies deal with areas such as Offspring and Urology as well as Endocrinology. In his research, Resistant hypertension is intimately related to Disease, which falls under the overarching field of Kidney disease.

Between 2007 and 2019, his most popular works were:

  • Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) (572 citations)
  • Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial (551 citations)
  • Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes (490 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Diabetes mellitus

Internal medicine, Endocrinology, Kidney disease, Cardiology and Renal function are his primary areas of study. His Internal medicine research is multidisciplinary, incorporating perspectives in Diabetes mellitus and Surgery. His work deals with themes such as Disease and Urology, which intersect with Endocrinology.

His Kidney disease research incorporates elements of Gastroenterology, Proteinuria, Hemodialysis and Intensive care medicine. The Cardiology study combines topics in areas such as Quartile and Left ventricular hypertrophy. His study focuses on the intersection of Renal function and fields such as Creatinine with connections in the field of Nephrology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmond J Lewis;Lawrence G Hunsicker;William R Clarke;Tomas Berl.
The New England Journal of Medicine (2001)

8540 Citations

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Christoph Wanner;Vera Krane;Winfried März;Manfred Olschewski.
The New England Journal of Medicine (2005)

3038 Citations

Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency

Giuseppe Maschio;Daniele Alberti;Gérard Janin;Francesco Locatelli.
The New England Journal of Medicine (1996)

2244 Citations

The Heidelberg classification of renal cell tumours

Gyula Kovacs;Mohammed Akhtar;Bruce J. Beckwith;Peter Bugert.
The Journal of Pathology (1997)

1539 Citations

Nephron number in patients with primary hypertension.

Gunhild Keller;Gisela Zimmer;Gerhard Mall;Eberhard Ritz.
The New England Journal of Medicine (2003)

1179 Citations

Association of a human G-protein β3 subunit variant with hypertension

W Siffert;D Rosskopf;G Siffert;S Busch.
Nature Genetics (1998)

1071 Citations

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

Eberhard Ritz;Ivan Rychlík;Francesco Locatelli;Serge Halimi.
American Journal of Kidney Diseases (1999)

1034 Citations

Nephropathy in Patients with Type 2 Diabetes Mellitus

Eberhard Ritz;Stephan Reinhold Orth.
The New England Journal of Medicine (1999)

1016 Citations

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

Hermann Haller;Sadayoshi Ito;Joseph L. Izzo;Andrzej Januszewicz.
The New England Journal of Medicine (2011)

911 Citations

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

Charles A. Herzog;Charles A. Herzog;Richard W. Asinger;Richard W. Asinger;Alan K. Berger;David M. Charytan.
Kidney International (2011)

863 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Eberhard Ritz

George L. Bakris

George L. Bakris

University of Chicago

Publications: 175

Dick de Zeeuw

Dick de Zeeuw

University Medical Center Groningen

Publications: 174

Giuseppe Remuzzi

Giuseppe Remuzzi

Mario Negri Institute for Pharmacological Research

Publications: 166

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh

University of California, Irvine

Publications: 162

Winfried März

Winfried März

Heidelberg University

Publications: 162

Stefan Pilz

Stefan Pilz

Medical University of Graz

Publications: 148

Luis M. Ruilope

Luis M. Ruilope

European University of Madrid

Publications: 146

Christoph Wanner

Christoph Wanner

University of Würzburg

Publications: 145

Peter Rossing

Peter Rossing

Steno Diabetes Center

Publications: 140

Carmine Zoccali

Carmine Zoccali

National Academies of Sciences, Engineering, and Medicine

Publications: 137

Hiddo J.L. Heerspink

Hiddo J.L. Heerspink

George Institute for Global Health

Publications: 125

Matthew R. Weir

Matthew R. Weir

University of Maryland, Baltimore

Publications: 124

Gerjan Navis

Gerjan Navis

University Medical Center Groningen

Publications: 114

Csaba P. Kovesdy

Csaba P. Kovesdy

University of Tennessee Health Science Center

Publications: 106

Raymond Vanholder

Raymond Vanholder

Ghent University Hospital

Publications: 103

David W. Johnson

David W. Johnson

University of Queensland

Publications: 101

Something went wrong. Please try again later.